Clinical Cymru Can Compete on Costs says PRA
PRA International says technology and IT innovation will help it compete with rivals that have moved their service centres to cheaper locations in the East to cut costs.
Archives for May 14, 2013
Dedicated Analytical Expansion Could Target New Clients, says Kemwell
Kemwell says expansion of its Indian analytical services will service a major client but is part of an active growth strategy.
Wuxi Manufacturing Services Help Increase Quarterly Earnings
Better than expected growth in Wuxi’s manufacturing services has driven the CRO to exceed its earlier guidance in the first quarter of 2013.
West Adds Second Filling line in Prep for Future Crystal Zenith Boom
Extra filling capacity is to be made available in preparation for West’s Crystal Zenith (CZ) system, though approval and increased sales are still at least 18 months away.
Yusen to Fly AstraZeneca's Drugs to Australia
Yusen Logistics has launched a new air freight service to help UK drug major AstraZeneca ship its products to Australia in a new agreement announced today.
Ranbaxy Pleads Guilty to Manufacturing Adulterated Drugs
In the largest US generic drug safety settlement ever, Ranbaxy USA has agreed to pay $500m after pleading guilty to manufacturing and distributing adulterated drugs, according to the US Justice Department settlement agreement.
Coalition Calls for Science-Based Approach to Elemental Impurity Testing
Differences in elemental impurity standards being developed separately by the US Pharmacopeia and ICH could mean costly reformulations according to a pharmaceutical, API and excipient industry coalition.
DISPATCHES FROM INTERPHEX
ATMI: Single-Use Could Replace Multi-Use, as Potency Increases
Single-use is set to dominate biopharma processing as products become more potent resulting in smaller volumes, according to ATMI.